Investor mix
21 investors on record; lead investors include DBJ Capital, Keio Innovation Initiative, Nissay Capital, Miraca Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 48% |
| Other / undisclosed | 11 | 52% |
Developer of recombinant protein drugs for neuro, renal and oncology disorders
21 investors on record; lead investors include DBJ Capital, Keio Innovation Initiative, Nissay Capital, Miraca Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 48% |
| Other / undisclosed | 11 | 52% |